Jarrard DF - Search Results

1

Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.

Marshall JR, Tangen CM, Sakr WA, Wood DP Jr, Berry DL, Klein EA, Lippman SM, Parnes HL, Alberts DS, Jarrard DF, Lee WR, Gaziano JM, Crawford ED, Ely B, Ray M, Davis W, Minasian LM, Thompson IM Jr. Marshall JR, et al. Among authors: jarrard df. Cancer Prev Res (Phila). 2011 Nov;4(11):1761-9. doi: 10.1158/1940-6207.CAPR-10-0343. Epub 2011 Sep 6. Cancer Prev Res (Phila). 2011. PMID: 21896650 Free PMC article. Clinical Trial.

2

Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy.

Gee JR, Saltzstein DR, Messing E, Kim K, Kolesar J, Huang W, Havighurst TC, Harris L, Wollmer BW, Jarrard D, House M, Parnes H, Bailey HH. Gee JR, et al. Eur J Cancer Prev. 2016 Jul;25(4):312-20. doi: 10.1097/CEJ.0000000000000189. Eur J Cancer Prev. 2016. PMID: 26313229 Clinical Trial.

3

A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance.

Jarrard D, Filon M, Huang W, Havighurst T, DeShong K, Kim K, Konety BR, Saltzstein D, Mukhtar H, Wollmer B, Suen C, House MG, Parnes HL, Bailey HH. Jarrard D, et al. Prostate. 2021 Jan;81(1):41-49. doi: 10.1002/pros.24076. Epub 2020 Oct 23. Prostate. 2021. PMID: 33095939 Clinical Trial.

4

Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D₃) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomy.

Jarrard D, Konety B, Huang W, Downs T, Kolesar J, Kim KM, Havighurst T, Slaton J, House MG, Parnes HL, Bailey HH. Jarrard D, et al. Am J Clin Exp Urol. 2016 Sep 20;4(2):17-27. eCollection 2016. Am J Clin Exp Urol. 2016. PMID: 27766277 Free PMC article.

5

Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.

Kibel AS, Rosenbaum E, Kattan MW, Picus J, Dreicer R, Klein EA, Chatta GS, Nelson JB, DiPaola RS, Roth BJ, Cookson MS, Wilding G, Jarrard DF, Beer TM, Ryan CW, Petrylak DP, Benson MC, Partin AW, Garrett-Mayer E, Eisenberger MA. Kibel AS, et al. Among authors: jarrard df. J Urol. 2007 May;177(5):1777-81. doi: 10.1016/j.juro.2007.01.028. J Urol. 2007. PMID: 17437819 Clinical Trial.

6

Validation of an epigenetic field of susceptibility to detect significant prostate cancer from non-tumor biopsies.

Yang B, Etheridge T, McCormick J, Schultz A, Khemees TA, Damaschke N, Leverson G, Woo K, Sonn GA, Klein EA, Fumo M, Huang W, Jarrard DF. Yang B, et al. Among authors: jarrard df. Clin Epigenetics. 2019 Nov 28;11(1):168. doi: 10.1186/s13148-019-0771-5. Clin Epigenetics. 2019. PMID: 31779677 Free PMC article.

7

Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin.

Gee J, Bailey H, Kim K, Kolesar J, Havighurst T, Tutsch KD, See W, Cohen MB, Street N, Levan L, Jarrard D, Wilding G. Gee J, et al. Prostate. 2013 Jun;73(9):970-8. doi: 10.1002/pros.22644. Epub 2013 Jan 17. Prostate. 2013. PMID: 23335089 Free PMC article. Clinical Trial.

8

Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer.

Truong M, Slezak JA, Lin CP, Iremashvili V, Sado M, Razmaria AA, Leverson G, Soloway MS, Eggener SE, Abel EJ, Downs TM, Jarrard DF. Truong M, et al. Among authors: jarrard df. Cancer. 2013 Nov 15;119(22):3992-4002. doi: 10.1002/cncr.28303. Epub 2013 Sep 4. Cancer. 2013. PMID: 24006289 Free PMC article.

9

Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence.

Kruser TJ, Jarrard DF, Graf AK, Hedican SP, Paolone DR, Wegenke JD, Liu G, Geye HM, Ritter MA. Kruser TJ, et al. Among authors: jarrard df. Cancer. 2011 Jun 15;117(12):2629-36. doi: 10.1002/cncr.25824. Epub 2010 Dec 14. Cancer. 2011. PMID: 21656740 Free PMC article.

10

Loss of Igf2 Gene Imprinting in Murine Prostate Promotes Widespread Neoplastic Growth.

Damaschke NA, Yang B, Bhusari S, Avilla M, Zhong W, Blute ML Jr, Huang W, Jarrard DF. Damaschke NA, et al. Among authors: jarrard df. Cancer Res. 2017 Oct 1;77(19):5236-5247. doi: 10.1158/0008-5472.CAN-16-3089. Epub 2017 Aug 3. Cancer Res. 2017. PMID: 28775169 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters